BioNTech SE Operating Expenses 2019-2024 | BNTX

BioNTech SE operating expenses for the twelve months ending September 30, 2024 were $4.316B, a 29.76% increase year-over-year.

  • BioNTech SE annual operating expenses for 2023 were $3.386B, a 31.15% decline from 2022.
  • BioNTech SE annual operating expenses for 2022 were $4.918B, a 12.57% increase from 2021.
  • BioNTech SE annual operating expenses for 2021 were $4.369B, a 577.26% increase from 2020.

BioNTech SE Operating Expenses 2019-2024 | BNTX

  • BioNTech SE annual operating expenses for 2023 were $3.386B, a 31.15% decline from 2022.
  • BioNTech SE annual operating expenses for 2022 were $4.918B, a 12.57% increase from 2021.
  • BioNTech SE annual operating expenses for 2021 were $4.369B, a 577.26% increase from 2020.